モノクローナル抗体治療剤の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Monoclonal Antibody Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16102 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、モノクローナル抗体治療剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。モノクローナル抗体治療剤の種類別市場規模（ヒト化抗体、ヒトマウスキメラ抗体）、用途別市場規模（がん、自己免疫疾患、感染症、血液疾患、眼疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、AbbVie、Sanofi、F. Hoffmann-La Roche、Novartis、Pfizer、Johnson & Johnson、Merck、GlaxoSmithKline、Amgen、Bristol-Myers Squibb Company、Biogen ・地域別グローバル市場分析 2015年-2020年 ・モノクローナル抗体治療剤の北米市場（アメリカ、カナダ、メキシコ） ・モノクローナル抗体治療剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・モノクローナル抗体治療剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・モノクローナル抗体治療剤の南米市場（ブラジル、アルゼンチン） ・モノクローナル抗体治療剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒト化抗体、ヒトマウスキメラ抗体 ・用途別分析：がん、自己免疫疾患、感染症、血液疾患、眼疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Monoclonal Antibody Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 146500 million by 2025, from USD 112440 million in 2019.

The Monoclonal Antibody Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Monoclonal Antibody Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Monoclonal Antibody Therapeutics market has been segmented into:
Humanized Antibody
Human Mouse Chimeric Antibody

By Application, Monoclonal Antibody Therapeutics has been segmented into:
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Monoclonal Antibody Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Monoclonal Antibody Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Monoclonal Antibody Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Monoclonal Antibody Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Monoclonal Antibody Therapeutics Market Share Analysis
Monoclonal Antibody Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Monoclonal Antibody Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Monoclonal Antibody Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Monoclonal Antibody Therapeutics are:
Bayer
AbbVie
Sanofi
F. Hoffmann-La Roche
Novartis
Pfizer
Johnson & Johnson
Merck
GlaxoSmithKline
Amgen
Bristol-Myers Squibb Company
Biogen

レポート目次

---

Table of Contents

1 Monoclonal Antibody Therapeutics Market Overview
1.1 Product Overview and Scope of Monoclonal Antibody Therapeutics
1.2 Classification of Monoclonal Antibody Therapeutics by Type
1.2.1 Global Monoclonal Antibody Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Type in 2019
1.2.3 Humanized Antibody
1.2.4 Human Mouse Chimeric Antibody
1.3 Global Monoclonal Antibody Therapeutics Market by Application
1.3.1 Overview: Global Monoclonal Antibody Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Global Monoclonal Antibody Therapeutics Market by Regions
1.4.1 Global Monoclonal Antibody Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Monoclonal Antibody Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Monoclonal Antibody Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Monoclonal Antibody Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Monoclonal Antibody Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Monoclonal Antibody Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Monoclonal Antibody Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche SWOT Analysis
2.4.4 F. Hoffmann-La Roche Product and Services
2.4.5 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amgen SWOT Analysis
2.10.4 Amgen Product and Services
2.10.5 Amgen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bristol-Myers Squibb Company
2.11.1 Bristol-Myers Squibb Company Details
2.11.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bristol-Myers Squibb Company SWOT Analysis
2.11.4 Bristol-Myers Squibb Company Product and Services
2.11.5 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biogen SWOT Analysis
2.12.4 Biogen Product and Services
2.12.5 Biogen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Monoclonal Antibody Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Monoclonal Antibody Therapeutics Players Market Share
3.2.2 Top 10 Monoclonal Antibody Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Monoclonal Antibody Therapeutics Revenue and Market Share by Regions
4.2 North America Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Monoclonal Antibody Therapeutics Revenue by Countries
5.1 North America Monoclonal Antibody Therapeutics Revenue by Countries (2015-2020)
5.2 USA Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Monoclonal Antibody Therapeutics Revenue by Countries
6.1 Europe Monoclonal Antibody Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Countries
7.1 Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Countries (2015-2020)
7.2 China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Monoclonal Antibody Therapeutics Revenue by Countries
8.1 South America Monoclonal Antibody Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Monoclonal Antibody Therapeutics by Countries
9.1 Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Monoclonal Antibody Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Monoclonal Antibody Therapeutics Market Forecast by Type (2019-2024)
10.3 Humanized Antibody Revenue Growth Rate (2015-2025)
10.4 Human Mouse Chimeric Antibody Revenue Growth Rate (2015-2025)
11 Global Monoclonal Antibody Therapeutics Market Segment by Application
11.1 Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Monoclonal Antibody Therapeutics Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Autoimmune Diseases Revenue Growth (2015-2020)
11.5 Infection Revenue Growth (2015-2020)
11.6 Hematological Diseases Revenue Growth (2015-2020)
11.7 Ophthalmological Diseases Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Monoclonal Antibody Therapeutics Market Size Forecast (2021-2025)
12.1 Global Monoclonal Antibody Therapeutics Market Size Forecast (2021-2025)
12.2 Global Monoclonal Antibody Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Monoclonal Antibody Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Monoclonal Antibody Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Monoclonal Antibody Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Monoclonal Antibody Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bayer Corporate Information, Location and Competitors
Table 6. Bayer Monoclonal Antibody Therapeutics Major Business
Table 7. Bayer Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Bayer SWOT Analysis
Table 9. Bayer Monoclonal Antibody Therapeutics Product and Solutions
Table 10. Bayer Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AbbVie Corporate Information, Location and Competitors
Table 12. AbbVie Monoclonal Antibody Therapeutics Major Business
Table 13. AbbVie Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. AbbVie SWOT Analysis
Table 15. AbbVie Monoclonal Antibody Therapeutics Product and Solutions
Table 16. AbbVie Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Monoclonal Antibody Therapeutics Major Business
Table 19. Sanofi Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Monoclonal Antibody Therapeutics Product and Solutions
Table 22. Sanofi Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 24. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Major Business
Table 25. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. F. Hoffmann-La Roche SWOT Analysis
Table 27. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product and Solutions
Table 28. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Monoclonal Antibody Therapeutics Major Business
Table 31. Novartis Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Monoclonal Antibody Therapeutics Product and Solutions
Table 34. Novartis Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Corporate Information, Location and Competitors
Table 36. Pfizer Monoclonal Antibody Therapeutics Major Business
Table 37. Pfizer Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Pfizer SWOT Analysis
Table 39. Pfizer Monoclonal Antibody Therapeutics Product and Solutions
Table 40. Pfizer Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Johnson & Johnson Corporate Information, Location and Competitors
Table 42. Johnson & Johnson Monoclonal Antibody Therapeutics Major Business
Table 43. Johnson & Johnson Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Johnson & Johnson SWOT Analysis
Table 45. Johnson & Johnson Monoclonal Antibody Therapeutics Product and Solutions
Table 46. Johnson & Johnson Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck Corporate Information, Location and Competitors
Table 48. Merck Monoclonal Antibody Therapeutics Major Business
Table 49. Merck Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Merck SWOT Analysis
Table 51. Merck Monoclonal Antibody Therapeutics Product and Solutions
Table 52. Merck Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GlaxoSmithKline Corporate Information, Location and Competitors
Table 54. GlaxoSmithKline Monoclonal Antibody Therapeutics Major Business
Table 55. GlaxoSmithKline Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. GlaxoSmithKline SWOT Analysis
Table 57. GlaxoSmithKline Monoclonal Antibody Therapeutics Product and Solutions
Table 58. GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Amgen Corporate Information, Location and Competitors
Table 60. Amgen Monoclonal Antibody Therapeutics Major Business
Table 61. Amgen Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Amgen SWOT Analysis
Table 63. Amgen Monoclonal Antibody Therapeutics Product and Solutions
Table 64. Amgen Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 66. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Major Business
Table 67. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Bristol-Myers Squibb Company SWOT Analysis
Table 69. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product and Solutions
Table 70. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Biogen Corporate Information, Location and Competitors
Table 72. Biogen Monoclonal Antibody Therapeutics Major Business
Table 73. Biogen Monoclonal Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. Biogen SWOT Analysis
Table 75. Biogen Monoclonal Antibody Therapeutics Product and Solutions
Table 76. Biogen Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Monoclonal Antibody Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 78. Global Monoclonal Antibody Therapeutics Revenue Share by Players (2015-2020)
Table 79. Global Monoclonal Antibody Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Monoclonal Antibody Therapeutics Revenue Market Share by Regions (2015-2020)
Table 81. North America Monoclonal Antibody Therapeutics Revenue by Countries (2015-2020)
Table 82. North America Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 83. Europe Monoclonal Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Monoclonal Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Monoclonal Antibody Therapeutics Revenue by Countries (2015-2020)
Table 86. South America Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Monoclonal Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 89. Global Monoclonal Antibody Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 90. Global Monoclonal Antibody Therapeutics Revenue Share by Type (2015-2020)
Table 91. Global Monoclonal Antibody Therapeutics Revenue Forecast by Type (2021-2025)
Table 92. Global Monoclonal Antibody Therapeutics Revenue by Application (2015-2020)
Table 93. Global Monoclonal Antibody Therapeutics Revenue Share by Application (2015-2020)
Table 94. Global Monoclonal Antibody Therapeutics Revenue Forecast by Application (2021-2025)
Table 95. Global Monoclonal Antibody Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Monoclonal Antibody Therapeutics Picture
Figure 2. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type in 2019
Figure 3. Humanized Antibody Picture
Figure 4. Human Mouse Chimeric Antibody Picture
Figure 5. Monoclonal Antibody Therapeutics Revenue Market Share by Application in 2019
Figure 6. Cancer Picture
Figure 7. Autoimmune Diseases Picture
Figure 8. Infection Picture
Figure 9. Hematological Diseases Picture
Figure 10. Ophthalmological Diseases Picture
Figure 11. Others Picture
Figure 12. Global Monoclonal Antibody Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Monoclonal Antibody Therapeutics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Monoclonal Antibody Therapeutics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Monoclonal Antibody Therapeutics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Monoclonal Antibody Therapeutics Revenue Market Share by Regions in 2018
Figure 26. North America Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. South America Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. North America Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Monoclonal Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 33. USA Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 38. Germany Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. UK Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. France Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 45. China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. South America Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Monoclonal Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 52. Brazil Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Monoclonal Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Global Monoclonal Antibody Therapeutics Revenue Share by Type (2015-2020)
Figure 61. Global Monoclonal Antibody Therapeutics Revenue Share by Type in 2019
Figure 62. Global Monoclonal Antibody Therapeutics Market Share Forecast by Type (2021-2025)
Figure 63. Global Humanized Antibody Revenue Growth Rate (2015-2020)
Figure 64. Global Human Mouse Chimeric Antibody Revenue Growth Rate (2015-2020)
Figure 65. Global Monoclonal Antibody Therapeutics Revenue Share by Application (2015-2020)
Figure 66. Global Monoclonal Antibody Therapeutics Revenue Share by Application in 2019
Figure 67. Global Monoclonal Antibody Therapeutics Market Share Forecast by Application (2021-2025)
Figure 68. Global Cancer Revenue Growth Rate (2015-2020)
Figure 69. Global Autoimmune Diseases Revenue Growth Rate (2015-2020)
Figure 70. Global Infection Revenue Growth Rate (2015-2020)
Figure 71. Global Hematological Diseases Revenue Growth Rate (2015-2020)
Figure 72. Global Ophthalmological Diseases Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Monoclonal Antibody Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Monoclonal Antibody Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Europe Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. South America Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---